Safety, tolerability and pharmacokinetics of censavudin in healthy male volunteer
Phase of Trial: Phase I
Latest Information Update: 27 Dec 2013
At a glance
- Drugs Censavudine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Oncolys BioPharma
- 10 Feb 2009 Results will be reported at CROI 2008, according to an OSI Pharmaceuticals media release.
- 10 Feb 2009 Status changed from planning to completed, according to a OSI Pharmaceuticals media release.
- 22 Apr 2008 New trial record.